Fareed Zakaria GPS: The gene editing revolution
CNN
The race to build better CRISPR delivery vehicles is heating up
STAT News
Meet the man who combines science, technology and magic to understand proteins
Marketplace
AI gene editing tools have power to modify human DNA, say researchers
BBC
AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality
STAT News
How crops are being disaster-proofed
BBC
New medicine could prevent disease before it begins — but at a cost
Financial Times
Generative A.I. Arrives in the Gene Editing World of CRISPR
The New York Times
Artificial intelligence is taking over drug development
The Economist
Sam Altman’s mission to increase human lifespan with a $180 million shipping container experiment at Retro Biosciences
Business Insider
Profluent Secures $35M in Additional Funding and Key Industry Experts to Scale Foundational AI Models for Biomedicine and Tackle First Vertical in Gene Editing
Thermal
Gene-editing pioneer calls for big investment in Crispr technology
Financial Times
Biotech VCs See Room for More Growth in Obesity Drug Market
The Wall St. Journal
Antibiotic Resistance is a Looming Crisis. CRISPR May Hold the Answer
WIRED
BioAge raises $170M as obesity spotlight shifts to oral options, muscle preservers
Endpoints News
BioAge Announces $170 Million Oversubscribed Series D Financing to Accelerate Development of Obesity and Metabolic Disease Therapeutics
Thermal
The Age of CRISPR: Engineering the Future of Genetic Medicine
TED
Innovative Genomics Institute and Danaher Join Forces to Accelerate and Scale Up the Development of CRISPR Cures
Thermal
Gene Editing Needs to Be for Everyone
WIRED
The Most Secretive Longevity Lab Finally Opens Its Doors
Bloomberg BusinessWeek
The First Crispr Therapy Is Just the Start of the Gene-Editing Revolution
Bloomberg News
FDA approves first gene-editing treatment for human illness
NPR
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
The New York Times
FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease
The Wall St. Journal
FDA approves two sickle cell therapies, including first CRISPR medicine
The Washington Post
FDA Approves First CRISPR Treatment in U.S.
TIME
The CRISPR Era Is Here
The Atlantic
Gene Editing Will Change Medicine—and Maybe Health Investing Too
The Wall St. Journal
Key questions (and answers) about the historic approval of a CRISPR-based medicine
STAT News
The Hard Problems issue
MIT Technology Review
The FDA Must Decide Whether Crispr’s Gene-Editing Promise Is Worth the Risk
Bloomberg BusinessWeek
FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease
NPR
Crispr Pioneer Jennifer Doudna Has the Guts to Take On the Microbiome
WIRED
age1 Launches to Advance The Longevity Fund’s Mission to Extend Healthy Lifespan
Thermal
Former Google AI expert raises $100mn for biotech start-up
Financial Times
Former Google AI leader lands $100M Series A raise for ‘biological software’ startup
Endpoints News
Want to live healthier longer? Visual guide shows how longevity science looks to slow diseases of aging
USA Today
How We Age—and How Scientists Are Working to Turn Back the Clock
The Wall St. Journal
This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions
Forbes